Neuropathic pain is a complex, chronic pain condition that is accompanied by tissue injury. In neuropathic pain, the nerve fibers may be damaged, dysfunctional, or injured. These nerve fibers send incorrect signals to other pain centers. The impact of nerve fiber injury creates a change in nerve function at the site of injury and areas surrounding the injury.

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

Key market highlights

PART 05: An overview of neuropathic pain

PART 06: Market landscape

Market overview

Five forces analysis

PART 07: Pipeline landscape

PART 08: Market segmentation by indication

Diabetic neuropathy

Chemotherapy-induced neuropathy pain

Postherpetic neuralgia

Others

PART 09: Market segmentation by drug class

Calcium channel alpha 2-delta ligands

Serotonin-norepinephrine reuptake inhibitors (SNRIs)

TCAs

Opioid analgesics

Others

PART 10: Geographical segmentation

Neuropathy pain treatment market in Americas

Neuropathy pain treatment market in EMEA

Neuropathy pain treatment market in APAC

PART 11: Decision framework

PART 12: Drivers and challenges

Market drivers

Impact of drivers on key customer segments

Market challenges

Impact of challenges on key customer segments

PART 13: Market trends

Development of topical patches for the treatment of

neuropathic pain likely to change market dynamics

Growing focus on emerging economies

Increasing mergers and acquisitions would lead to further

consolidation

PART 14: Vendor landscape

Competitive scenario

PART 15: Key vendor analysis

Depomed

Eli Lilly

Endo International

Pfizer

Other prominent vendors

PART 16: Appendix

List of abbreviations

PART 17: Explore Technavio